Human Vaccines & Immunotherapeutics (Dec 2020)

Global scenario, public health concerns and mitigation strategies to counter current ongoing SARS-CoV-2 / COVID-19 pandemic

  • Sukhadeo Baliram Barbuddhe,
  • Deepak Bhiwa Rawool,
  • Pankaj Prakash Gaonkar,
  • Jess Vergis,
  • Kuldeep Dhama,
  • Satyaveer Singh Malik

DOI
https://doi.org/10.1080/21645515.2020.1810496
Journal volume & issue
Vol. 16, no. 12
pp. 3023 – 3033

Abstract

Read online

Severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), the etiological agent of the novel coronavirus disease (COVID-19), has posed a great public health threat to the global community as a pandemic. The origin of the virus has been linked to animals, through a yet-to-be-identified intermediate host. The disease is transmitted to humans mainly through inhalation or contact with infected droplets. The variable clinical presentation of COVID-19 includes fever, cough, sore throat, breathlessness, fatigue and malaise; however, cutaneous, ocular, neurological, and gastrointestinal manifestations have also been reported. There is an urgent need to strengthen One Health surveillance, intervention, and management strategies to understand the ecology of coronaviruses and to prevent epidemics in the future. Global attention toward the development of treatments, immunotherapies, vaccines, and control options to combat the COVID-19 pandemic has been on an increasing trend. Here, we review the current epidemiological status, public health concerns, and mitigation strategies for COVID-19.

Keywords